Cellmid Ltd
ASX:CDY
Cellmid Ltd
Research & Development
Cellmid Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cellmid Ltd
ASX:CDY
|
Research & Development
-AU$118.8k
|
CAGR 3-Years
42%
|
CAGR 5-Years
20%
|
CAGR 10-Years
18%
|
|
|
Holista CollTech Ltd
ASX:HCT
|
Research & Development
-AU$30k
|
CAGR 3-Years
43%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Bioxyne Ltd
ASX:BXN
|
Research & Development
-AU$174.7k
|
CAGR 3-Years
-57%
|
CAGR 5-Years
17%
|
CAGR 10-Years
-10%
|
|
|
McPherson's Ltd
ASX:MCP
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Star Combo Pharma Ltd
ASX:S66
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
Biome Australia Ltd
ASX:BIO
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cellmid Ltd
Glance View
Cellmid Ltd. operates as a biotechnology company, which engages in the development and marketing of therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-12-09. The firm is specialized in developing anti-aging solutions. The firm operates through two segments: Diagnostics and Consumer Health. The firm is engaged in the research and development of diagnostic and therapeutic products for the management of diseases, such as cancer and various chronic inflammatory conditions by targeting midkine. The company is also engaged in the development and sale of over the counter (OTC) and cosmetic products for hair loss and anti-aging hair care through its FGF5 inhibitor technology. The company has developed a range of products under the evolis, evolis Professional, Lexilis Hybrid, Jo-JuRED and Lexilis BLACK brands.
See Also
What is Cellmid Ltd's Research & Development?
Research & Development
-118.8k
AUD
Based on the financial report for Jun 30, 2021, Cellmid Ltd's Research & Development amounts to -118.8k AUD.
What is Cellmid Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
18%
The average annual Research & Development growth rates for Cellmid Ltd have been 42% over the past three years , 20% over the past five years , and 18% over the past ten years .
